cyclopentane has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Augoff, K; Hryniewicz-Jankowska, A; Sossey-Alaoui, K; Stach, K; Tabola, R; Wierzbicki, J | 1 |
1 other study(ies) available for cyclopentane and Esophageal Squamous Cell Carcinoma
Article | Year |
---|---|
The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma.
Topics: Cell Line, Tumor; Cell Movement; Cyclopentanes; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; NEDD8 Protein; Neoplasm Invasiveness; NF-KappaB Inhibitor alpha; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Pyrimidines; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Ubiquitin-Activating Enzymes | 2021 |